|
|
|
| home > white papers > Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring - Dycem |
|
|
 WHITE PAPERS |
|
Dycem
|
|
Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring
|
|
A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
First own Gerresheimer Autoinjector - Gerresheimer and Midas Pharma announce strategic partnership
– Gerresheimer’s first own IP autoinjector suitable for both
small and large molecules enhances broad portfolio of solutions, medical
devices and pharmaceutical primary packaging
–
First joint project of Gerresheimer and Midas Pharma: Development and
marketing of new autoinjector
– One-stop-shop for biotech and pharma
customers
Duesseldorf, November 08, 2021 –
Gerresheimer acquired the IP of a new generation cartridge based
autoinjector from Midas Pharma. This is the start of a strategic
partnership. The joint project comprises the development and marketing
of the new generation autoinjector.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trial Labelling – More Than Just Labels
Faubel & Co. Nachfolger GmbH
Deciding which label is best for a particular trial project is not always easy. Labels have become multifunctional tools which are able to convey variable data in different languages, indicate first opening, product originality, support ease of use or blind study drugs. They are no longer used as mere carriers of specified contents.
More info >> |
|
|
|
